US20040159374A1 - Titanium alloy composition having a major phase of alpha" - Google Patents
Titanium alloy composition having a major phase of alpha" Download PDFInfo
- Publication number
- US20040159374A1 US20040159374A1 US10/778,173 US77817304A US2004159374A1 US 20040159374 A1 US20040159374 A1 US 20040159374A1 US 77817304 A US77817304 A US 77817304A US 2004159374 A1 US2004159374 A1 US 2004159374A1
- Authority
- US
- United States
- Prior art keywords
- titanium alloy
- alloy composition
- phase
- work piece
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229910001069 Ti alloy Inorganic materials 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 33
- 239000010936 titanium Substances 0.000 claims abstract description 18
- 229910052750 molybdenum Inorganic materials 0.000 claims abstract description 11
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 10
- 229910052721 tungsten Inorganic materials 0.000 claims abstract description 9
- 229910052758 niobium Inorganic materials 0.000 claims abstract description 8
- 229910052715 tantalum Inorganic materials 0.000 claims abstract description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 6
- 239000012535 impurity Substances 0.000 claims description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 229910052804 chromium Inorganic materials 0.000 claims description 3
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 229910052748 manganese Inorganic materials 0.000 claims description 3
- 229910052759 nickel Inorganic materials 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 238000001816 cooling Methods 0.000 abstract description 12
- 238000010791 quenching Methods 0.000 abstract description 5
- 230000000171 quenching effect Effects 0.000 abstract description 5
- 238000000034 method Methods 0.000 description 15
- 238000005452 bending Methods 0.000 description 9
- 229910045601 alloy Inorganic materials 0.000 description 8
- 239000000956 alloy Substances 0.000 description 8
- 239000010453 quartz Substances 0.000 description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 5
- 229910052719 titanium Inorganic materials 0.000 description 5
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 4
- 229910000883 Ti6Al4V Inorganic materials 0.000 description 4
- 238000005266 casting Methods 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 230000000399 orthopedic effect Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000002844 melting Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 239000004053 dental implant Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000005555 metalworking Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000036316 preload Effects 0.000 description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 244000137852 Petrea volubilis Species 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 238000002441 X-ray diffraction Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000010952 cobalt-chrome Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000008376 long-term health Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 238000013001 point bending Methods 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C22—METALLURGY; FERROUS OR NON-FERROUS ALLOYS; TREATMENT OF ALLOYS OR NON-FERROUS METALS
- C22C—ALLOYS
- C22C14/00—Alloys based on titanium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/04—Metals or alloys
- A61L27/06—Titanium or titanium alloys
Definitions
- the present invention is related to a titanium alloy composition having a major phase of ⁇ ”, and to a process for making a work piece having a major phase of ⁇ ” from a titanium alloy, and in particular to a process for making a biocompatible low modulus high strength titanium-based medical device having a major phase of ⁇ ”.
- Titanium and titanium alloys have been popularly used in many medical applications due to their light weight, excellent mechanical performance and corrosion resistance.
- the relatively low strength commercially pure titanium (c.p. Ti) is currently used as dental implant, crown and bridge, as well as denture framework.
- c.p. Ti Commercially pure titanium
- Ti-6Al-4V alloy has been widely used in a variety of stress-bearing orthopedic applications, such as hip prosthesis and artificial knee joint.
- the lower elastic modulus allows the titanium alloy to more closely approximate the stiffness of bone for use in orthopedic devices compared to alternative stainless steel and cobalt-chrome alloys in orthopedic implants.
- devices formed from the titanium alloy produce less bone stress shielding and consequently interfere less with bone viability.
- a primary objective of the present invention is to provide a process for making said work piece, and in particular a biocompatible low modulus high strength medical device, from a titanium alloy free from potential harmful components.
- Another objective of the present invention is to provide a process for making a work piece, and in particular a biocompatible low modulus high strength medical device, from a titanium alloy composition having a major phase of ⁇ ”.
- the present invention provides a titanium alloy composition comprising at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti, wherein said composition has a Mo equivalent value from about 6 to about 9, and has an ⁇ ” phase as a major phase.
- the titanium alloy composition of the present invention is substantially free from an eutectoid beta stabilizing element selected from the group consisting of Fe, Mn, Cr, Co, and Ni.
- titanium alloy composition of the present invention is substantially free from Al.
- the titanium alloy composition of the present invention is substantially free from V.
- the titanium alloy composition of the present invention consists essentially of at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti.
- the titanium alloy composition of the present invention comprises one or more incidental impurities selected from the group consisting of carbon, oxygen and nitrogen, wherein a total amount of said one or more incidental impurities is less than 1 wt %
- the present invention provides a process for making a work piece having an ⁇ ” phase as a major phase from a titanium alloy according to the present invention comprises the following steps:
- a) preparing a titanium alloy composition comprising at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti, wherein said composition has a Mo equivalent value from about 6 to about 9;
- said titanium alloy composition in step a) is substantially free from an eutectoid beta stabilizing element selected from the group consisting of Fe, Mn, Cr, Co, and Ni.
- said titanium alloy composition in step a) is substantially free from Al.
- said titanium alloy composition in step a) is substantially free from V.
- said titanium alloy composition in step a) consists essentially of at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti.
- said cooling rate is greater than 20° C./sec.
- said fast cooling in step b) comprises water quenching.
- said composition has a temperature of 800-1200° C. before said fast cooling in step b).
- said preparing in step a) of the process of the present invention comprises casting said titanium alloy composition to form a work piece having a temperature higher than 800° C.
- said fast cooling in step b) comprises fast cooling said work piece having a temperature higher than 800° C.
- said preparing in step a) of the process of the present invention comprises metal working said titanium alloy composition to form a work piece, and heating the resulting work piece to a temperature higher than 800° C.
- said fast cooling in step b) comprises fast cooling said work piece having a temperature higher than 800° C.
- said titanium alloy composition in step a) further comprises one or more incidental impurities selected from the group consisting of carbon, oxygen and nitrogen, wherein a total amount of said one or more incidental impurities is less than 1 wt %.
- said work piece having a major phase of ⁇ ” is a medical device.
- [Mo]wt %, [Nb]wt %, [Ta]wt % and [W]wt % are percentages of Mo, Nb, Ta and W, respectively, based on the weight of the composition.
- the casting and the metal working suitable for use in the process of the present invention are not limited, and can be any known techniques in the art.
- a typical quenching method used in the process of the present application is water quenching; however, any methods known in the art which have a cooling rate greater than 10° C., preferably 20° C., per second, can also be used.
- the medical device prepared by the process of the present invention can be an orthopedic implant, a dental implant, a dental crown, a dental bridge or a denture framework.
- Ti-7.5Mo alloy (7.5 wt % Mo) was prepared from a commercially pure titanium (c.p. Ti) bar, and molybdenum of 99.95% purity using a commercial arc-melting vacuum-pressure type casting system (Castmatic, Iwatani Corp., Japan). The melting chamber was first evacuated and purged with argon. An argon pressure of 1.5 kgf/cm 2 was maintained during melting. Appropriate amounts of the c.p. Ti bar and molybdenum wire (92.5 wt % Ti- 7.5 wt % Mo) were melted in a U-shaped copper hearth with a tungsten electrode. The ingot was re-melted three times to improve chemical homogeneity.
- a specimen having an outer diameter of 7 mm and a length of 29 mm was prepared from the Ti-7.5Mo alloy, at one end of which was further provided with a hole having a diameter of 3.5 mm and a depth of 12 mm for mounting a K-type thermalcouple therein.
- a titanium in the form of a sponge was received in a quartz tube and fixed at a bottom thereof by a quartz cap, and the specimen equipped with the thermalcouple was inserted into the quartz tube and hermetically mounted inside the quartz tube with one end of the thermalcouple being connected to a temperature recorder (ss. 250 Recorder, Sekonic, Japan).
- the quartz tube at the sealed end was further equipped with a vacuum pump, and a vacuum meter.
- the quartz tube was vacuumed for five minutes, and placed in an air furnace (s19, Nabertherm®, Germany) preheated at 1000° C. for 30 minutes.
- the quartz tube was removed from the air furnace, and the specimen together with the thermalcouple was subjected to water quenching.
- the average cooling rates recorded was 118° C./sec.
- X-ray diffraction for phase analysis of the cooled specimen was conducted using a Rigaku diffractometer (Rigaku D-max IIIV, Rigaku Co., Tokyo, Japan) operated at 30 kV and 20 mA.
- a Ni-filtered CuK ⁇ radiation was used for this study.
- a silicon standard was used for calibration of diffraction angles. Scanning speed of 3°/min was used.
- the phase was identified by matching each characteristic peak in the diffraction pattern with the JCPDS files.
- ⁇ bending strength (MPa); P is load (Kg); L is span length (mm); b is specimen width (mm) and h is specimen thickness (mm).
- the average bending strength and modulus of elasticity in bending were taken from at least six tests under each condition.
- the Ti alloys prepared according to the process of the present invention all have an ⁇ ” phase, and have a high bending strength and a low modulus (high strength/modulus ratios) compared to the prior art Ti-6Al-4V alloy.
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Mechanical Engineering (AREA)
- Metallurgy (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
- The present application is a continuation-in-part application of U.S. patent application Ser. No. 10/327,992, filed Dec. 26, 2002, which is a continuation-in-part application of U.S. patent application Ser. No. 10/157,121, filed May 30, 2002, which is a continuation-in-part application of U.S. patent application Ser. No. 10/134,524, filed Apr. 30, 2002, which is a continuation-in-part application of U.S. patent application Ser. No. 09/226,204, filed Jan. 7, 1999, now U.S. Pat. No. 6,409,852B1. The above-listed applications are commonly assigned with the present invention and the entire contents of which are incorporated herein by reference.
- The present invention is related to a titanium alloy composition having a major phase of α”, and to a process for making a work piece having a major phase of α” from a titanium alloy, and in particular to a process for making a biocompatible low modulus high strength titanium-based medical device having a major phase of α”.
- Titanium and titanium alloys have been popularly used in many medical applications due to their light weight, excellent mechanical performance and corrosion resistance. The relatively low strength commercially pure titanium (c.p. Ti) is currently used as dental implant, crown and bridge, as well as denture framework. With a much higher strength than c.p. Ti, Ti-6Al-4V alloy has been widely used in a variety of stress-bearing orthopedic applications, such as hip prosthesis and artificial knee joint. Moreover, the lower elastic modulus allows the titanium alloy to more closely approximate the stiffness of bone for use in orthopedic devices compared to alternative stainless steel and cobalt-chrome alloys in orthopedic implants. Thus, devices formed from the titanium alloy produce less bone stress shielding and consequently interfere less with bone viability.
- Various attempts at providing low modulus, high strength titanium alloys for making medical implants with less stress shielding have been proffered by the prior art. There is still a great interest in finding a lower modulus and higher strength titanium alloys. In addition, studies have reported that the release of Al and V ions from the medical implants might cause some long-term health problems, for example the low wear resistance of Ti-6Al-4V alloy could accelerate the release of such harmful ions.
- A primary objective of the present invention is to provide a process for making said work piece, and in particular a biocompatible low modulus high strength medical device, from a titanium alloy free from potential harmful components.
- Another objective of the present invention is to provide a process for making a work piece, and in particular a biocompatible low modulus high strength medical device, from a titanium alloy composition having a major phase of α”.
- In order to achieve the aforesaid objectives the present invention provides a titanium alloy composition comprising at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti, wherein said composition has a Mo equivalent value from about 6 to about 9, and has an α” phase as a major phase.
- Preferably, the titanium alloy composition of the present invention is substantially free from an eutectoid beta stabilizing element selected from the group consisting of Fe, Mn, Cr, Co, and Ni.
- Preferably, titanium alloy composition of the present invention is substantially free from Al.
- Preferably, the titanium alloy composition of the present invention is substantially free from V.
- Preferably, the titanium alloy composition of the present invention consists essentially of at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti.
- Preferably, the titanium alloy composition of the present invention comprises one or more incidental impurities selected from the group consisting of carbon, oxygen and nitrogen, wherein a total amount of said one or more incidental impurities is less than 1 wt %
- The present invention provides a process for making a work piece having an α” phase as a major phase from a titanium alloy according to the present invention comprises the following steps:
- a) preparing a titanium alloy composition comprising at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti, wherein said composition has a Mo equivalent value from about 6 to about 9;
- b) fast cooling said composition having a temperature higher than 800° C. to a temperature lower than 500° C. at a cooling rate greater than 10° C./second between 800-500° C., so that the resulting cooled composition contains an α” phase as a major phase.
- Preferably, said titanium alloy composition in step a) is substantially free from an eutectoid beta stabilizing element selected from the group consisting of Fe, Mn, Cr, Co, and Ni.
- Preferably, said titanium alloy composition in step a) is substantially free from Al.
- Preferably, said titanium alloy composition in step a) is substantially free from V.
- Preferably, said titanium alloy composition in step a) consists essentially of at least one isomorphous beta stabilizing element selected from the group consisting of Mo, Nb, Ta and W; and the balance Ti.
- Preferably, said cooling rate is greater than 20° C./sec.
- Preferably, said fast cooling in step b) comprises water quenching.
- Preferably, said composition has a temperature of 800-1200° C. before said fast cooling in step b).
- Preferably, said preparing in step a) of the process of the present invention comprises casting said titanium alloy composition to form a work piece having a temperature higher than 800° C., and said fast cooling in step b) comprises fast cooling said work piece having a temperature higher than 800° C.
- Preferably, said preparing in step a) of the process of the present invention comprises metal working said titanium alloy composition to form a work piece, and heating the resulting work piece to a temperature higher than 800° C., and said fast cooling in step b) comprises fast cooling said work piece having a temperature higher than 800° C.
- Preferably, said titanium alloy composition in step a) further comprises one or more incidental impurities selected from the group consisting of carbon, oxygen and nitrogen, wherein a total amount of said one or more incidental impurities is less than 1 wt %.
- Preferably, said work piece having a major phase of α” is a medical device.
- In the present invention, said Mo equivalent value, [Mo]eq, can be represented by the following equation:
- [Mo]eq=[Mo]+0.28[Nb]+0.22[Ta]+0.44[W]
- wherein [Mo]wt %, [Nb]wt %, [Ta]wt % and [W]wt % are percentages of Mo, Nb, Ta and W, respectively, based on the weight of the composition.
- The casting and the metal working suitable for use in the process of the present invention are not limited, and can be any known techniques in the art.
- A typical quenching method used in the process of the present application is water quenching; however, any methods known in the art which have a cooling rate greater than 10° C., preferably 20° C., per second, can also be used.
- The medical device prepared by the process of the present invention can be an orthopedic implant, a dental implant, a dental crown, a dental bridge or a denture framework.
- Some of the preferred embodiments according to the present invention will be described in the following examples, that are intended as illustrative only since numerous modifications and variations therein will be apparent to those skilled in the art.
- Ti-7.5Mo alloy (7.5 wt % Mo) was prepared from a commercially pure titanium (c.p. Ti) bar, and molybdenum of 99.95% purity using a commercial arc-melting vacuum-pressure type casting system (Castmatic, Iwatani Corp., Japan). The melting chamber was first evacuated and purged with argon. An argon pressure of 1.5 kgf/cm2 was maintained during melting. Appropriate amounts of the c.p. Ti bar and molybdenum wire (92.5 wt % Ti- 7.5 wt % Mo) were melted in a U-shaped copper hearth with a tungsten electrode. The ingot was re-melted three times to improve chemical homogeneity.
- A specimen having an outer diameter of 7 mm and a length of 29 mm was prepared from the Ti-7.5Mo alloy, at one end of which was further provided with a hole having a diameter of 3.5 mm and a depth of 12 mm for mounting a K-type thermalcouple therein. A titanium in the form of a sponge was received in a quartz tube and fixed at a bottom thereof by a quartz cap, and the specimen equipped with the thermalcouple was inserted into the quartz tube and hermetically mounted inside the quartz tube with one end of the thermalcouple being connected to a temperature recorder (ss. 250 Recorder, Sekonic, Japan). The quartz tube at the sealed end was further equipped with a vacuum pump, and a vacuum meter. The quartz tube was vacuumed for five minutes, and placed in an air furnace (s19, Nabertherm®, Germany) preheated at 1000° C. for 30 minutes. The quartz tube was removed from the air furnace, and the specimen together with the thermalcouple was subjected to water quenching. The average cooling rates recorded was 118° C./sec.
- X-ray diffraction (XRD) for phase analysis of the cooled specimen was conducted using a Rigaku diffractometer (Rigaku D-max IIIV, Rigaku Co., Tokyo, Japan) operated at 30 kV and 20 mA. A Ni-filtered CuKα radiation was used for this study. A silicon standard was used for calibration of diffraction angles. Scanning speed of 3°/min was used. The phase was identified by matching each characteristic peak in the diffraction pattern with the JCPDS files.
- Three-point bending tests were performed using a desk-top mechanical tester (Shimadzu AGS-500D, Tokyo, Japan) operated at 0.5 mm/sec. Reduced size (36×5×1 mm) specimens were cut from the castings and polished using sand paper to a #1000 level. The bending strengths were determined using the equation,
- σ=3PL/2bh2
- where σ is bending strength (MPa); P is load (Kg); L is span length (mm); b is specimen width (mm) and h is specimen thickness (mm). The modulus of elasticity in bending was calculated from the load increment and the corresponding deflection increment between the two points on a straight line as far apart as possible using the equation, E=L3ΔP/4bh3Δδwhere E is modulus of elasticity in bending (Pa); ΔP is load increment as measured from preload (N); and Δδ is deflection increment at midspan as measured from preload. The average bending strength and modulus of elasticity in bending were taken from at least six tests under each condition.
- Various Ti alloys were also prepared and tested according to the aforesaid procedures in Example 1. Table 1 lists the weight percentages of the starting metals in the preparation of the Ti alloys of the present invention and the test results thereof, wherein data of the c.p. Ti (Grade II) and Ti-6Al-4V alloy are also included for comparison.
TABLE 1 Strength/ Bending Bending modulus strength modulus ratio Alloy system [Mo]eq Phase (MPa) (GPa) (×103) Ti-7.5Mo 7.5 α″ 1395 55 25.4 Ti-17.5Nb 4.9 α″ 1472 59.4 24.8 Ti-20Nb 5.6 α″ 1466 60.4 24.3 Ti-22.5Nb 6.2 α″ 1509 68.5 22.0 Ti-25Nb 6.9 α″ 1656 77.1 21.5 Ti-5Mo-12.5Ta 7.5 α″ 1525 69.2 22.0 Ti-5Mo-15Ta 8.0 α″ 1497 66.7 22.4 Ti-6Mo-5Nb 7.4 α″ 1477 69.1 21.3 Ti-6Mo-7Ta 7.54 α″ 1489 70.4 21.1 Ti-6Mo-3W 7.32 α″ 1401 64.6 21.6 Ti-7.5Mo-1Nb 7.78 α″ 1680 64 26.3 Ti-7.5Mo-2.5Ta 8.0 α″ 1649 66.9 24.6 Ti-7.5Mo-5Ta 8.5 α″ 1724 71.2 24.2 Ti-7.5Mo-7.5Ta 9.0 α″ 1759 73 24.1 Tu-6Mo-3Nb-3Ta 7.5 α″ 1436 67.6 21.2 Ti-6Mo-3Nb-1.5W 7.5 α″ 1398 66.9 20.8 Ti-6Mo-3Ta-1.5W 7.32 α″ 1451 65.2 22.2 c.p. Ti (Grade II) 0 α′ 884 92 9.6 Ti-6A1-4V 2.7 α + β 1857 105 17.7 - It can be seen from Table 1 that the Ti alloys prepared according to the process of the present invention all have an α” phase, and have a high bending strength and a low modulus (high strength/modulus ratios) compared to the prior art Ti-6Al-4V alloy.
- Although the present invention has been described with reference to specific details of certain embodiments thereof, it is not intended that such details should be regarded as limitations upon the scope of the invention except as and to the extent that they are included in the accompanying claims. Many modifications and variations are possible in light of the above disclosure.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/778,173 US20040159374A1 (en) | 1999-01-07 | 2004-02-17 | Titanium alloy composition having a major phase of alpha" |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/226,204 US6409852B1 (en) | 1999-01-07 | 1999-01-07 | Biocompatible low modulus titanium alloy for medical implant |
US10/134,524 US6752882B2 (en) | 1999-01-07 | 2002-04-30 | Medical implant made of biocompatible low modulus high strength titanium-niobium alloy and method of using the same |
US10/157,121 US6723189B2 (en) | 1999-01-07 | 2002-05-30 | Process for making a work piece having a major phase of α″ from a titanium alloy |
US10/327,992 US6726787B2 (en) | 1999-01-07 | 2002-12-26 | Process for making a work piece having a major phase of α from a titanium alloy |
US10/778,173 US20040159374A1 (en) | 1999-01-07 | 2004-02-17 | Titanium alloy composition having a major phase of alpha" |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/327,992 Continuation-In-Part US6726787B2 (en) | 1999-01-07 | 2002-12-26 | Process for making a work piece having a major phase of α from a titanium alloy |
Publications (1)
Publication Number | Publication Date |
---|---|
US20040159374A1 true US20040159374A1 (en) | 2004-08-19 |
Family
ID=32854450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/778,173 Abandoned US20040159374A1 (en) | 1999-01-07 | 2004-02-17 | Titanium alloy composition having a major phase of alpha" |
Country Status (1)
Country | Link |
---|---|
US (1) | US20040159374A1 (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080314737A1 (en) * | 2005-10-20 | 2008-12-25 | Mark Gaydos | Methods of Making Molybdenium Titanium Sputtering Plates and Targets |
US8449817B2 (en) | 2010-06-30 | 2013-05-28 | H.C. Stark, Inc. | Molybdenum-containing targets comprising three metal elements |
US8449818B2 (en) | 2010-06-30 | 2013-05-28 | H. C. Starck, Inc. | Molybdenum containing targets |
WO2013085993A1 (en) * | 2011-12-06 | 2013-06-13 | Chien-Ping Ju | METHOD FOR INCREASING MECHANICAL STRENGTH OF TITANIUM ALLOYS HAVING α" PHASE BY COLD WORKING |
US9334565B2 (en) | 2012-05-09 | 2016-05-10 | H.C. Starck Inc. | Multi-block sputtering target with interface portions and associated methods and articles |
US9334562B2 (en) | 2011-05-10 | 2016-05-10 | H.C. Starck Inc. | Multi-block sputtering target and associated methods and articles |
CN107119208A (en) * | 2017-05-12 | 2017-09-01 | 北京市劳动保护科学研究所 | A kind of Ti Nb Mn alloys and preparation method thereof |
-
2004
- 2004-02-17 US US10/778,173 patent/US20040159374A1/en not_active Abandoned
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110097236A1 (en) * | 2005-10-20 | 2011-04-28 | H. C. Starck Inc. | Methods of making molybdenum titanium sputtering plates and targets |
US8911528B2 (en) | 2005-10-20 | 2014-12-16 | H.C. Starck Inc. | Methods of making molybdenum titanium sputtering plates and targets |
US20080314737A1 (en) * | 2005-10-20 | 2008-12-25 | Mark Gaydos | Methods of Making Molybdenium Titanium Sputtering Plates and Targets |
US9150955B2 (en) | 2010-06-30 | 2015-10-06 | H.C. Starck Inc. | Method of making molybdenum containing targets comprising molybdenum, titanium, and tantalum or chromium |
US8449817B2 (en) | 2010-06-30 | 2013-05-28 | H.C. Stark, Inc. | Molybdenum-containing targets comprising three metal elements |
US8449818B2 (en) | 2010-06-30 | 2013-05-28 | H. C. Starck, Inc. | Molybdenum containing targets |
US9945023B2 (en) | 2010-06-30 | 2018-04-17 | H.C. Starck, Inc. | Touch screen device comprising Mo-based film layer and methods thereof |
US9837253B2 (en) | 2010-06-30 | 2017-12-05 | H.C. Starck Inc. | Molybdenum containing targets for touch screen device |
US9017762B2 (en) | 2010-06-30 | 2015-04-28 | H.C. Starck, Inc. | Method of making molybdenum-containing targets comprising three metal elements |
US9334562B2 (en) | 2011-05-10 | 2016-05-10 | H.C. Starck Inc. | Multi-block sputtering target and associated methods and articles |
EP2788519A4 (en) * | 2011-12-06 | 2015-05-20 | Univ Nat Cheng Kung | Method for increasing mechanical strength of titanium alloys having " phase by cold working |
JP2015507689A (en) * | 2011-12-06 | 2015-03-12 | ジェイユー,チェン−ピン | Method for improving the mechanical strength of titano alloys with α "phase by cold working |
US9404170B2 (en) | 2011-12-06 | 2016-08-02 | National Cheng Kung University | Method for increasing mechanical strength of titanium alloys having α″ phase by cold working |
CN104245994A (en) * | 2011-12-06 | 2014-12-24 | 朱建平 | Method for increasing mechanical strength of titanium alloys having alpha'' phase by cold working |
WO2013085993A1 (en) * | 2011-12-06 | 2013-06-13 | Chien-Ping Ju | METHOD FOR INCREASING MECHANICAL STRENGTH OF TITANIUM ALLOYS HAVING α" PHASE BY COLD WORKING |
US9334565B2 (en) | 2012-05-09 | 2016-05-10 | H.C. Starck Inc. | Multi-block sputtering target with interface portions and associated methods and articles |
US10643827B2 (en) | 2012-05-09 | 2020-05-05 | H.C. Starck Inc. | Multi-block sputtering target with interface portions and associated methods and articles |
CN107119208A (en) * | 2017-05-12 | 2017-09-01 | 北京市劳动保护科学研究所 | A kind of Ti Nb Mn alloys and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6752882B2 (en) | Medical implant made of biocompatible low modulus high strength titanium-niobium alloy and method of using the same | |
US7722805B2 (en) | Titanium alloy with extra-low modulus and superelasticity and its producing method and processing thereof | |
JP3330380B2 (en) | Hot implant, method of manufacturing the same, and alloy useful for hot implant | |
EP0359446B1 (en) | High strength, low modulus titanium alloy | |
CA1100339A (en) | Cobalt-chromium-molybdenum alloy containing nitrogen | |
Lee et al. | Structure and properties of titanium–25 niobium–x iron alloys | |
CN101768685A (en) | Biomedical titanium-niobium-based shape memory alloy as well as preparation method, processing method and application method thereof | |
US6726787B2 (en) | Process for making a work piece having a major phase of α from a titanium alloy | |
US20040159374A1 (en) | Titanium alloy composition having a major phase of alpha" | |
US6723189B2 (en) | Process for making a work piece having a major phase of α″ from a titanium alloy | |
US20090088845A1 (en) | Titanium tantalum oxygen alloys for implantable medical devices | |
CN112662914A (en) | Low-elastic-modulus high-plasticity titanium alloy and preparation method and application thereof | |
AU2023201949A1 (en) | Titanium based ceramic reinforced alloy | |
US9039963B2 (en) | Titanium based ceramic reinforced alloy for use in medical implants | |
US20060231178A1 (en) | Method of making an article of a titanium alloy by plastically deforming at room temperature and/or polishing | |
EP2927334B1 (en) | Titanium based ceramic reinforcement alloy for use in medical implants | |
US20130139933A1 (en) | Method for enhancing mechanical strength of a titanium alloy by aging | |
JP6494172B2 (en) | Ceramic reinforced titanium-based alloy for use in medical implants | |
Hsu et al. | Effect of thermomechanical treatment on structure and properties of metastable Ti-25Nb-8Sn alloy | |
AU2014201877B2 (en) | Titanium based ceramic reinforced alloy for use in medical implants | |
CA2847938C (en) | Titanium based ceramic reinforced alloy for use in medical implants | |
JP2000087160A (en) | Titanium alloy for living body | |
CN116334445A (en) | Rare earth doped Ti-Nb-Dy alloy and preparation and processing methods thereof | |
CN116334446A (en) | Rare earth element Y doped Ti-Nb based titanium alloy and preparation and processing methods thereof | |
CN115369285A (en) | Low-modulus metastable beta titanium alloy, preparation method thereof and metal implant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: LIN, JIIN-HUEY CHERN, ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIN, JIIN-HUEY CHERN;JU, CHIEN-PING;LEE, CHIH-MIN;REEL/FRAME:015770/0136 Effective date: 20040216 Owner name: JU, CHIEN-PING, ILLINOIS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIN, JIIN-HUEY CHERN;JU, CHIEN-PING;LEE, CHIH-MIN;REEL/FRAME:015770/0136 Effective date: 20040216 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |